Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)
Public ClinicalTrials.gov record NCT04322682. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 3, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection and have at least one high-risk criterion. Approximately 6000 subjects meeting all inclusion and no exclusion criteria will be randomized to receive either colchicine or placebo tablets for 30 days.
Study identification
- NCT ID
- NCT04322682
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 4,506 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 22, 2020
- Primary completion
- Jan 20, 2021
- Completion
- Jan 20, 2021
- Last update posted
- Dec 12, 2024
2020 – 2021
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic - Phoenix | Phoenix | Arizona | 85054 | — |
| Yuma Regional Medical Center Cancer Center | Yuma | Arizona | 85364 | — |
| Centric Health Resources Inc. | Bakersfield | California | 93308 | — |
| Westside Medical Associates of Los Angeles | Beverly Hills | California | 90211 | — |
| Rancho Research Institute | Downey | California | 90242 | — |
| University of California San Francisco - Zuckerberg San Francisco General Hospital | San Francisco | California | 94110 | — |
| Mayo Clinic - Jacksonville | Jacksonville | Florida | 32224 | — |
| South Florida Research Organization | Medley | Florida | 33166 | — |
| Miami Center for Advanced Cardiology | Miami Beach | Florida | 33140 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| North Mississippi Medical Clinics, Inc. | Tupelo | Mississippi | 38801 | — |
| New York Langone Health | New York | New York | 10010 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Baylor Scott & White Research Institute - Pharmacy | Dallas | Texas | 75246 | — |
| University of Texas(UT) Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Spring Clinical Research | Houston | Texas | 77002 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04322682, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 12, 2024 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04322682 live on ClinicalTrials.gov.